2 hours ago
This study focused on the potential of MX1, OAS1, and RSAD2 genes as biomarkers for predicting the efficacy of biological therapies for psoriasis.
Source: onlinelibrary.wiley.com
*Funding: Hubei Polytechnic University | Natural Science Foundation of Hubei Province.
Quote:
This study aims to explore the genes that have predictive value for the effect of biologic therapy and provide a basis for personalized therapy in psoriasis. We analyzed gene expression data from seven publicly available datasets from the Gene Expression Omnibus (GEO) database.
Differentially expressed immune-related genes (DEIRGs) were identified using the limma package, followed by gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. MX1, OAS1, and RSAD2 were identified using GSE2737 and GSE78097. Cross-dataset validation of MX1, OAS1, and RSAD2 expression dynamics was performed using pre- and post-treatment specimens from GSE69967, GSE51440, and GSE11903. The expression levels of MX1, OAS1, and RSAD2 in clinical samples before and after treatment were further evaluated using an immunohistochemical (IHC) assay.
The expression levels of MX1 and OAS1 in psoriatic lesional skin were positively correlated with PASI scores, and their expression in post-treatment lesions was significantly reduced compared to pretreatment lesions. RSAD2 expression in psoriatic lesional skin demonstrated no significant correlation with PASI scores, and its expression levels remained statistically unchanged between pretreatment and post-treatment psoriatic skin lesions.
Baseline expression of MX1 and OAS1 differed significantly between responders and nonresponders, whereas RSAD2 showed no significant intergroup difference. Owing to the small and imbalanced sample (17 responders vs 3 nonresponders) with complete group separation for MX1/OAS1, these results require cautious interpretation. MX1 and OAS1 may serve as candidate biomarkers for monitoring biologic efficacy in psoriasis and warrant further validation in larger studies.
Source: onlinelibrary.wiley.com
*Funding: Hubei Polytechnic University | Natural Science Foundation of Hubei Province.


Health Boards
